| Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D‐Aromatic‐Boron‐Rich‐Cluster into the 4‐Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment M Couto, MF García, C Alamón, M Cabrera, P Cabral, A Merlino, ... Chemistry–A European Journal 24 (13), 3122-3126, 2018 | 56 | 2018 |
| 99mTc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging MF García, X Zhang, M Shah, J Newton-Northup, P Cabral, H Cerecetto, ... Bioorganic & medicinal chemistry 24 (6), 1209-1215, 2016 | 53 | 2016 |
| Characterization of Spanish isolates of Pseudomonas corrugata from tomato and pepper MM Lopez, F Siverio, MR Albiach, F Garcia, R Rodriguez Plant pathology 43 (1), 80-90, 1994 | 33 | 1994 |
| [99mTc (CO) 3]-radiolabeled bevacizumab: in vitro and in vivo evaluation in a melanoma model X Camacho, MF García, V Calzada, M Fernández, JA Chabalgoity, ... Oncology 84 (4), 200-209, 2013 | 28 | 2013 |
| Sunitinib-containing carborane pharmacophore with the ability to inhibit tyrosine kinases receptors FLT3, KIT and PDGFR-β, exhibits powerful in vivo anti-glioblastoma activity C Alamón, B Dávila, MF García, C Sánchez, M Kovacs, E Trias, L Barbeito, ... Cancers 12 (11), 3423, 2020 | 27 | 2020 |
| Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron … M Couto, C Alamón, MF García, M Kovacs, E Trias, S Nievas, E Pozzi, ... Cells 9 (6), 1408, 2020 | 27 | 2020 |
| Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody MF Garcia, V Calzada, X Camacho, E Goicochea, J Pablo Gambini, ... Current Radiopharmaceuticals 7 (2), 84-90, 2014 | 23 | 2014 |
| Technetium-99m-or Cy7-labeled rituximab as an imaging agent for non-Hodgkin lymphoma X Camacho, CL Machado, MF García, JP Gambini, A Banchero, ... Oncology 92 (4), 229-242, 2017 | 20 | 2017 |
| Synthesis of hydrophilic HYNIC-[1,2,4,5]tetrazine conjugates and their use in antibody pretargeting with 99mTc. MF García, F Gallazzi, MS Junqueira, M Fernández, X Camacho, ... Organic Biomolecular Chemistry 16 (29), 5275-5285, 2018 | 17 | 2018 |
| Derivatizations of Sgc8‐c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations E Sicco, J Báez, J Margenat, F García, M Ibarra, P Cabral, M Moreno, ... Chemical Biology & Drug Design 91 (3), 747-755, 2018 | 16 | 2018 |
| Familia: aspectos claves C Ortiz, M García Medellín, Corporación para investigaciones biológicas, 2013 | 16 | 2013 |
| 99mTc-labeled Bevacizumab vía HYNIC for Imaging of Melanoma X Camacho, MF García, V Calzada, M Fernandez, O Alonso, JP Gambini, ... Journal of Analytical Oncology 3 (1), 53-64, 2014 | 15 | 2014 |
| Fab (nimotuzumab)-HYNIC-99mTc: Antibody fragmentation for molecular imaging agents V Calzada, MF García, LM Alonso-Martínez, X Camachoc, E Goicochea, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 14 | 2016 |
| Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging M Fernanda Garcia, X Zhang, F Gallazzi, M Fernandez, M Moreno, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2015 | 14 | 2015 |
| Labeling and biological evaluation of 99mTc-HYNIC-Trastuzumab as a potential radiopharmaceutical for in vivo evaluation of HER2 expression in breast cancer V Calzada, F Garcia, M Fernández, W Porcal, T Quinn, O Alonso, ... World Journal of Nuclear Medicine 12 (1), 27, 2013 | 14 | 2013 |
| Synthesis and evaluation of 99mTc chelate-conjugated bevacizumab X Camacho, M Fernanda Garcia, V Calzada, M Fernández, W Porcal, ... Current Radiopharmaceuticals 6 (1), 12-19, 2013 | 13 | 2013 |
| Potenciales bioeléctricos: origen y registro M García, A Jiménez, MR Ortiz, MA Peña Universidad Autónoma Metropolitana. México. Unidad Iztapalapa, 195, 1998 | 12 | 1998 |
| Randomized, double-blind study on effectiveness of intra-alveolar chlorhexidine gel in reducing the incidence of alveolar osteítis in mandibular third molar surgery D Torres, JL Gutiérrez, P Infante, M Garcia, M Romero, MA Serrera Int J Oral Maxillofac Surg 35 (4), 348-51, 2006 | 11 | 2006 |
| Tocilizumab labeling with 99mTechnetium via HYNIC as a molecular diagnostic agent for multiple myeloma X Camacho, C Longo Machado, M Fernanda Garcia, M Fernández, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 10 | 2017 |
| Aspectos claves Familia C Ortiz, M García Medellin: Panamericana Formas e Impresos SA, 2013 | 10 | 2013 |
